MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gonzalez, F. J.
Right arrow Articles by Nebert, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gonzalez, F. J.
Right arrow Articles by Nebert, D. W.

Structural gene products of the Ah locus. Transcriptional regulation of cytochrome P1-450 and P3-450 mRNA levels by 3-methylcholanthrene

FJ Gonzalez, RH Tukey and DW Nebert

Mouse liver cytochromes P1-450 and P3-450 represent those forms of polycylic hydrocarbon-induced P-450 most closely associated with induced aryl hydrocarbon (benzo[a] pyrene) hydroxylase and acetanilide 4-hydroxylase activity, respectively. These two proteins are controlled by the Ah receptor: C57BL/6N mice possess the high-affinity receptor; DBA/2N mice, the poor-affinity receptor. 3-Methylcholanthrene at the highest dose technically possible induces both proteins in C57BL/6N but not DBA/2N mice, whereas sufficiently high doses of 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD) induce both proteins in both inbred mouse strains. Plasmids containing DNA complementary to P1-450 and P3- 450 mRNA, respectively, were used in an in vitro nuclear transcription assay to determine the mechanism of the induction response. In C57BL/6N mice, transcriptional rates of the P1-450 and P3-450 genes increase dramatically as early as 3 hr after 3-methylcholanthrene treatment and at 12 hr reach maximal levels of 20- and 15-fold, respectively, above control values. In contrast, no increase in either gene is found in 3- methylcholanthrene-treated DBA/2N mice. Following TCDD administration, both P1-450 and P3-450 gene transcription rates are elevated in DBA/2N mice. There is a 3- to 6-hr lag period between the early onset of enhanced transcription rates and the later rise in P1-450 and P3-450 mRNA. Basal and induced levels of P3-450 mRNA are about 5-fold greater than those of P1-450 mRNA. These data confirm that the 3- methylcholanthrene and TCDD induction responses, governed by the Ah receptor, are mediated principally through an increase in specific gene transcription.

Volume 26, Issue 1, pp. 117-121, 07/01/1984
Copyright © 1984 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
C. R. Chiaro, R. D. Patel, C. B. Marcus, and G. H. Perdew
Evidence for an Aryl Hydrocarbon Receptor-Mediated Cytochrome P450 Autoregulatory Pathway
Mol. Pharmacol., November 1, 2007; 72(5): 1369 - 1379.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
A. Anapolsky, S. Teng, S. Dixit, and M. Piquette-Miller
THE ROLE OF PREGNANE X RECEPTOR IN 2-ACETYLAMINOFLUORENE-MEDIATED INDUCTION OF DRUG TRANSPORT AND -METABOLIZING ENZYMES IN MICE
Drug Metab. Dispos., March 1, 2006; 34(3): 405 - 409.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. L. Thomae, E. A. Stevens, and C. A. Bradfield
Transforming Growth Factor-{beta}3 Restores Fusion in Palatal Shelves Exposed to 2,3,7,8-Tetrachlorodibenzo-p-dioxin
J. Biol. Chem., April 1, 2005; 280(13): 12742 - 12746.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
W. Zhang, B. Moorthy, M. Chen, K. Muthiah, R. Coffee, A. F. Purchio, and D. B. West
A Cyp1a2-Luciferase Transgenic CD-1 Mouse Model: Responses to Aryl Hydrocarbons Similar to the Humanized AhR Mice
Toxicol. Sci., November 1, 2004; 82(1): 297 - 307.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
L. Yu. Zacharova, L. F. Gulyaeva, V. V. Lyakhovich, O. N. Mikhailova, O. A. Timofeeva, M. L. Filipenko, and V. I. Kaledin
Cytochrome P4501A1 and 1A2 Gene Expression in the Liver of 3-Methylcholanthrene- and o-Aminoazotoluene-Treated Mice: A Comparison between PAH-Responsive and PAH-Nonresponsive Strains
Toxicol. Sci., May 1, 2003; 73(1): 108 - 113.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. K. Sindhu, M. Mitsuhashi, and Y. Kikkawa
Induction of Cytochrome P-450 1A2 by Oxidized Tryptophan in Hepa lclc7 Cells
J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 1008 - 1014.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Shimizu, Y. Nakatsuru, M. Ichinose, Y. Takahashi, H. Kume, J. Mimura, Y. Fujii-Kuriyama, and T. Ishikawa
Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor
PNAS, January 18, 2000; 97(2): 779 - 782.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Takahashi, K. Nakayama, S. Itoh, Y. Fujii-Kuriyama, and T. Kamataki
Inhibition of the Transcription of CYP1A1 Gene by the Upstream Stimulatory Factor 1 in Rabbits. COMPETITIVE BINDING OF USF1 WITH AhR·Arnt COMPLEX
J. Biol. Chem., November 28, 1997; 272(48): 30025 - 30031.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. G. Bacsi and O. Hankinson
Functional Characterization of DNA-binding Domains of the Subunits of the Heterodimeric Aryl Hydrocarbon Receptor Complex Imputing Novel and Canonical Basic Helix-Loop-Helix Protein-DNA Interactions
J. Biol. Chem., April 12, 1996; 271(15): 8843 - 8850.
[Abstract] [Full Text] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
F.J. Gonzalez, A.K. Jaiswal, and D.W. Nebert
P450 Genes: Evolution, Regulation, and Relationship To Human Cancer and Pharmacogenetics
Cold Spring Harb Symp Quant Biol, January 1, 1986; 51(0): 879 - 890.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1984 by the American Society for Pharmacology and Experimental Therapeutics